HubSpot
HUBS
$192.26
-6.23%
HubSpot, Inc. provides a comprehensive, cloud-based marketing, sales, and customer service software platform known as the growth platform, operating within the Software - Application industry. The company is a recognized leader in the inbound marketing and CRM space, distinguished by its integrated suite of tools designed to help small and medium-sized businesses grow better. The current investor narrative is dominated by a significant and rapid repricing of the stock, as evidenced by recent steep declines, which likely reflects broader market concerns over tech cost structures, the sustainability of growth, and the valuation of software-as-a-service (SaaS) companies in a potentially higher interest rate environment.…
HUBS
HubSpot
$192.26
HUBS 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on HubSpot's 12-month outlook, with a consensus price target around $249.94 and implied upside of +30.0% versus the current price.
Average Target
$249.94
13 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
13
covering this stock
Price Range
$154 - $250
Analyst target range
The stock is covered by 13 analysts, and recent institutional ratings from February 2026 show a unanimously bullish sentiment, with firms like Barclays, Citigroup, Wells Fargo, and RBC Capital all maintaining Buy, Overweight, or Outperform ratings. However, specific consensus price targets and the implied upside are not available in the provided dataset, preventing a calculation of the market's quantitative price expectation. The absence of explicit target data, despite strong qualitative buy-side sentiment, suggests analysts may be in the process of reassessing targets following the stock's precipitous ~50% year-to-date decline, leading to a period of high uncertainty and a potentially wide target range as they model new scenarios for growth and profitability.
Bulls vs Bears: HUBS Investment Factors
The evidence presents a stark dichotomy: compelling fundamentals and valuation on one side, versus catastrophic price action and sentiment on the other. The bear side currently has stronger short-term evidence, as the relentless downtrend and high volatility (beta 1.44) dominate the narrative. However, the bull case is built on a foundation of robust underlying business metrics that appear disconnected from the stock price. The single most important tension in the investment debate is whether the current forward PE of 12.6x represents a historic buying opportunity for a high-quality SaaS asset, or a value trap signaling permanently impaired growth prospects. The resolution hinges on HUBS's ability to demonstrate consistent profitability and re-accelerate revenue growth in its upcoming earnings reports.
Bullish
- Strong Forward PE Discount: The forward PE of 12.6x is a significant discount to the software industry average, especially for a company with 20%+ revenue growth and 83.7% gross margins. This suggests the market is undervaluing HUBS's future earnings power, as the trailing PE of 458.5x indicates a transition to profitability is already underway.
- Robust Revenue Growth & High Margins: Q4 2025 revenue grew 20.4% YoY to $846.3 million, demonstrating resilient demand. The company's gross margin of 83.7% confirms a highly scalable and profitable SaaS business model, providing a strong foundation for future earnings expansion as operating leverage improves.
- Healthy Balance Sheet & Cash Flow: HUBS has a strong financial position with a low debt-to-equity ratio of 0.23 and a current ratio of 1.52. The company generates substantial free cash flow ($677.3M TTM), providing internal funding for growth without reliance on dilutive financing, a key advantage in a risk-off market.
- Unanimous Analyst Buy Sentiment: All 13 covering analysts maintain Buy, Overweight, or Outperform ratings as of February 2026, indicating strong institutional conviction in the company's long-term prospects despite the severe price decline. This consensus suggests the fundamental story remains intact.
Bearish
- Severe Price & Momentum Downtrend: HUBS is in a sustained bear market, down -56.27% over 6 months and -25.80% over the past month, showing no signs of a reversal. With a beta of 1.44, it remains highly vulnerable to further market volatility and risk-off sentiment, as evidenced by its massive underperformance.
- Revenue Growth Deceleration: While still strong at 20.4%, Q4 2025 revenue growth decelerated from 23.3% in Q3 2025. In a market punishing growth stocks, any further slowdown could trigger multiple compression and validate bearish narratives about SaaS demand saturation or competitive pressures.
- Extremely High Trailing Valuation: The trailing PE of 458.5x, though down from historical peaks, remains astronomically high and indicates the stock is priced for flawless execution of margin expansion. Any earnings miss or guidance reduction would shatter this fragile valuation premise, leading to further downside.
- Profitability Remains Inconsistent: Despite a positive Q4 2025 net income of $54.4M, the company posted a net loss of -$32.6M in Q2 2025. This earnings volatility, with a net margin of just 6.4% in the latest quarter, raises questions about the sustainability and scalability of profits in the near term.
HUBS Technical Analysis
The stock is in a severe and sustained downtrend, with a 1-year price change of -62.95% and a 6-month decline of -56.27%. The current price of $192.26 sits near the bottom of its 52-week range, trading at approximately 28% of the range from a low of $187.45 to a high of $682.57, indicating the stock is deeply oversold and potentially in a capitulation phase. Recent momentum remains decisively negative, with the stock down -25.80% over the past month and -48.26% over the past three months, showing no meaningful divergence from the longer-term bearish trend and suggesting persistent selling pressure. Key technical support is at the 52-week low of $187.45, while resistance is far above at the 52-week high of $682.57; a breakdown below support could signal a continuation of the downtrend, while any recovery would face immense overhead supply. The stock's beta of 1.44 indicates it is 44% more volatile than the broader market, which has exacerbated its downside during this risk-off period, as evidenced by its -92.47% relative strength versus the S&P 500 over the past year.
Beta
1.44
1.44x market volatility
Max Drawdown
-71.4%
Largest decline past year
52-Week Range
$187-$683
Price range past year
Annual Return
-62.9%
Cumulative gain past year
| Period | HUBS Return | S&P 500 |
|---|---|---|
| 1m | -25.8% | +2.6% |
| 3m | -48.3% | -2.3% |
| 6m | -56.3% | +2.6% |
| 1y | -62.9% | +27.3% |
| ytd | -49.7% | -0.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HUBS Fundamental Analysis
Revenue growth remains robust but has shown some deceleration; the most recent quarterly revenue (Q4 2025) was $846.3 million, representing a 20.4% year-over-year increase, though this is a slowdown from the 23.3% YoY growth seen in the prior quarter (Q3 2025 revenue of $809.5 million). The company is marginally profitable, with Q4 2025 net income of $54.4 million and a net margin of 6.4%, a significant improvement from the net loss of -$32.6 million in Q2 2025; gross margins are exceptionally strong and stable at 83.7% for the quarter, indicating a highly scalable software business model. The balance sheet is healthy with a current ratio of 1.52 and a low debt-to-equity ratio of 0.23, while the company generates substantial free cash flow, with TTM free cash flow of $677.3 million, providing ample internal funding for operations and growth initiatives without reliance on excessive external financing.
Quarterly Revenue
$846327000.0B
2025-12
Revenue YoY Growth
+0.20%
YoY Comparison
Gross Margin
+0.83%
Latest Quarter
Free Cash Flow
$677288000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HUBS Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is an extremely high 458.5x, while the forward PE is a much lower 12.6x; this massive gap implies the market is pricing in a dramatic acceleration in earnings growth and a return to sustainable profitability after a period of investment. Compared to typical software industry averages, a forward PE of 12.6x would generally be considered a discount, especially for a company with 20%+ revenue growth and 80%+ gross margins, suggesting the market may be undervaluing its future earnings power. Historically, the stock's own trailing PE has fluctuated wildly, from negative values during loss-making periods to over 1,789x; the current 458.5x trailing multiple, while high, is below the peak seen in late 2024, but still indicates the stock is priced for near-perfect execution of its growth and margin expansion plans.
PE
458.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -2251x~1789x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
117.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on earnings volatility and valuation fragility. Despite a strong Q4, net income swung from a -$32.6M loss in Q2 2025 to a $54.4M profit, indicating profitability is not yet stable. The astronomical trailing PE of 458.5x makes the stock hypersensitive to any earnings miss. Furthermore, while revenue grew 20.4% YoY, the deceleration from 23.3% last quarter warrants monitoring; sustained slowing could break the growth narrative supporting the valuation.
Market & Competitive Risks are severe, dominated by valuation compression. The stock's beta of 1.44 means it falls 44% more than the market in downturns, as seen in its -92.47% relative strength over the past year. Trading at a forward PE of 12.6x, it may seem like a discount, but if sector multiples contract further or growth expectations are downgraded, the stock could re-rate lower. Competitive intensity in the CRM/marketing software space and macro sensitivity of its SMB customer base add to external pressures.
The Worst-Case Scenario involves a continuation of the growth scare and multiple compression. If Q1 2026 earnings show revenue growth decelerating below 15% and operating margins contracting, it could trigger a wave of analyst downgrades and a loss of investor confidence. This could lead to a test and break of the 52-week low of $187.45, potentially driving the stock toward the $150-160 range, representing a further downside of -17% to -22% from the current price of $192.26. The historical max drawdown of -71.4% shows the potential for extreme losses is real.